COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1662: Articles 16611-16620  | Next

Age specific COVID-19 undercount in Spain from the regional breakdown of 52-week accumulated mortality rates
Martin-Olalla, J. M.
10.1101/2021.03.15.21253667 — Posted: 2021-03-17
The course of the UK COVID 19 pandemic; no measurable impact of new variants.
Ellis, D., Mukherjee, S., Papadopoulos, D., Chari, N., Ukwu, U., Charitopoulos, K., Donkov, I., Bishara, S.
10.1101/2021.03.16.21253534 — Posted: 2021-03-17
COVID-19 with early neurological and cardiac thromboembolic phenomena--timeline of incidence and clinical features
Sundar, U., Merchant, S., Shah, M., Mukhopadhyay, A., Kolte, S., Darole, P., Mahajan, S., Bansal, A., Gosavi, S., Asole, D., Karnik, N., Mahajan, A., Joshi, A.
10.1101/2021.03.15.21253619 — Posted: 2021-03-17
PD-1highCXCR5-CD4+ Peripheral Helper T (Tph) cells Promote Tissue-Homing Plasmablasts in COVID-19
Asashima, H., Mohanty, S., Comi, M., Ruff, W. E., Hoehn, K. B., Wong, P., Cohen, I., Coffey, S., Raddassi, K., Chaudhary, O., Unterman, A., Emu, B., Kleinstein, S. H., Montgomery, R. R., Iwasaki, A., Dela Cruz, C. S., Kaminski, N., Shaw, A. C., Hafler, D. A., Sumida, T. S.
10.1101/2021.03.13.21253527 — Posted: 2021-03-17
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR cycle amplification values
Alizon, S., Selinger, C., Sofonea, M. T., Haim-Boukobza, S., Giannoli, J.-M., Ninove, L., Pillet, S., Vincent, T., de Rougemont, A., Tumiotto, C., Solis, M., Stephan, R., Bressollette-Bodin, C., Salmona, M., L'Honneur, A.-S., Behillil, S., Lefeuvre, C., Dina, J., Hantz, S., Hartard, C., Veyer, D., Delagreverie, H. M., Fourati, S., Visseaux, B., Henquell, C., Lina, B., Foulougne, V., Burrel, S.
10.1101/2021.03.15.21253653 — Posted: 2021-03-17
A bibliometric analysis of COVID-19 research in Africa
Guleid, F. H., Oyando, R., Kabia, E., Mumbi, A., Akech, S., Barasa, E.
10.1101/2021.03.15.21253589 — Posted: 2021-03-17
Faecal shedding models for SARS-CoV-2 RNA amongst hospitalised patients and implications for wastewater-based epidemiology
Hoffmann, T., Alsing, J.
10.1101/2021.03.16.21253603 — Posted: 2021-03-17
Hospitalisation rates differed by city district and ethnicity during the first wave of COVID-19 in Amsterdam, the Netherlands
Coyer, L., Wynberg, E., Buster, M., Wijffels, C., Prins, M., Schreijer, A., van Duijnhoven, Y. T. H. P., van Dam, A., van der Lubben, M., Leenstra, T.
10.1101/2021.03.15.21253597 — Posted: 2021-03-17
Real-World Effectiveness and Tolerability of Monoclonal Antibodies for Ambulatory Patients with Early COVID-19
Webb, B. J., Buckel, W., Vento, T., Butler, A. M., Grisel, N., Brown, S. M., Peltan, I. D., Spivak, E. S., Shah, M., Sakata, T., Wallin, A., Stenehjem, E., Poulsen, G., Bledsoe, J.
10.1101/2021.03.15.21253646 — Posted: 2021-03-17
Lessons learned from the resilience of Chinese hospitals to the COVID-19 pandemic: a scoping review.
Stennett, J., Hou, R., Traverson, L., Ridde, V., Zinszer, K., Chabrol, F.
10.1101/2021.03.15.21253509 — Posted: 2021-03-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).